Insider Buying: BioPharma Credit (LON:BPCR) Insider Acquires 20,000 Shares of Stock

Posted by Lauren Steadman on Mar 29th, 2024

BioPharma Credit (LON:BPCR – Get Free Report) insider Sapna Shah acquired 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 27th. The shares were bought at an average cost of GBX 72 ($0.91) per share, for a total transaction of £14,400 ($18,197.90).

BioPharma Credit Trading Down 1.0 %

Shares of BPCR stock opened at GBX 0.87 ($0.01) on Friday. BioPharma Credit has a twelve month low of GBX 0.81 ($0.01) and a twelve month high of GBX 0.98 ($0.01). The company has a market capitalization of £11.31 million, a price-to-earnings ratio of 6.69 and a beta of 0.21. The firm has a 50-day moving average price of GBX 0.91 and a 200 day moving average price of GBX 0.87.

BioPharma Credit Cuts Dividend

The company also recently announced a dividend, which will be paid on Tuesday, April 30th. Investors of record on Thursday, March 28th will be given a dividend of $0.02 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a yield of 1.97%. BioPharma Credit’s dividend payout ratio (DPR) is currently 5,384.62%.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.